Akero Therapeutics, Inc. ( AKRO) - Stock Earnings
Stock symbol AKRO is outdated, potentially delisted? Maybe it is available on other exchange?
AKRO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -31.1 million USD | — USD |
| 2023Q3 | -39.7 million USD | — USD |
| 2023Q4 | -55.2 million USD | 284000 USD |
AKRO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -100.7 million USD | 0 USD |
| 2022 | -108.9 million USD | 0 USD |
| 2023 | -151.8 million USD | — USD |
AKRO
Price: $54.65
52 week price:
Earnings Per Share: -3.75 USD
P/E Ratio: -14.52
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 143289
Market Capitalization: 4.5 billion